×
About 2,168 results

ALLMedicine™ Immunodeficiencies Center

Research & Reviews  816 results

Selected Abstracts from the VIIth Biennial Conference of African Society for Immunodefi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433048
Journal of Clinical Immunology;

Sep 12th, 2021 - Selected Abstracts from the VIIth Biennial Conference of African Society for Immunodeficiencies (ASID): ASID VII Online, Khartoum, October 1-2, 2021.|2021||

Gata2 haploinsufficiency promotes proliferation and functional decline of HSCs with mye...
https://doi.org/10.1182/bloodadvances.2021004726
Blood Advances; Abdelfattah AM, Hughes-Davies A et. al.

Sep 9th, 2021 - During aging, hematopoietic stem cell (HSC) function wanes with important biological and clinical implications for benign and malignant hematology, and other co-morbidities, such as cardiovascular disease. However, the molecular mechanisms regulat...

Secondary immunodeficiencies. An overview.
https://doi.org/10.1016/j.anai.2021.08.413
Annals of Allergy, Asthma & Immunology : Official Publica... Tuano KS, Seth N et. al.

Sep 6th, 2021 - To review the different causes of secondary immunodeficiencies and provide clinicians with an updated overview of potential factors that contribute to immunodeficiency. DATA SOURCES Recent published literature obtained through PubMed database sear...

In Utero Gene Therapy for Primary Immunodeficiencies.
https://doi.org/10.1097/GRF.0000000000000652
Clinical Obstetrics and Gynecology; Mardy AH, Norton ME

Sep 6th, 2021 - Primary immunodeficiencies (PIDs) have become a prime target for gene therapy given the morbidity, mortality, and the single gene etiology. Given that outcomes are better the earlier gene therapy is implemented, it is possible that fetal gene ther...

see more →

Guidelines  1 results

European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
https://doi.org/10.4193/Rhin20.600
Rhinology Fokkens WJ, Lund VJ et. al.

Feb 23rd, 2020 - The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and cle...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  1 results

Improving the Diagnosis of Common Variable Immune Deficiency
https://clinicaltrials.gov/ct2/show/NCT02680652

Abstract: An increased susceptibility to bacterial and viral infections is the hallmark of explain the study rationale, primary immunodeficiencies (PID). The most common PID requiring treatment with Ig replacement (SCIg or IVIg) is Common Variable...

see more →

News  37 results

Inborn Errors of Immunity May Show Diverse Presenting Manifestations
https://www.medscape.com/viewarticle/951609

May 24th, 2021 - NEW YORK (Reuters Health) - Infection is the most frequent initial presenting manifestation of inborn errors of immunity (IEI), but both immune dysregulation and syndromic features may be indicative of these rare diseases, according to an analysis...

Prolonged SARS-CoV-2 Shedding Possible With Immunocompromise
https://www.staging.medscape.com/viewarticle/940090

Nov 2nd, 2020 - NEW YORK (Reuters Health) - Shedding of infectious SARS-CoV-2 can continue for months in immunocompromised patients, according to a case report. "We weren't surprised that someone with immune problems might have a longer disease course and be cont...

Novel Study Explores Link Between Primary Immunodeficiencies, Rheumatic Diseases
https://www.medscape.com/viewarticle/939605

Oct 22nd, 2020 - Fully 48% of patients with autoimmune rheumatic diseases who developed persistent hypogammaglobulinemia after initiating treatment with immunomodulatory agents harbored gene variants associated with inborn errors of immunity, according to the find...

Novel Study Explores Link Between Primary Immunodeficiencies, Rheumatic Diseases
https://www.staging.medscape.com/viewarticle/939605

Oct 22nd, 2020 - Fully 48% of patients with autoimmune rheumatic diseases who developed persistent hypogammaglobulinemia after initiating treatment with immunomodulatory agents harbored gene variants associated with inborn errors of immunity, according to the find...

COVID-19 Outcomes Vary Widely in Patients With Primary Immunodeficiencies
https://www.medscape.com/viewarticle/939374

Oct 20th, 2020 - NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We were first surprised that we had only a few cases considering how ...

see more →